Amount Raised
83
45
Amount Raised
Growth Score
-6 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Ascenta Capital is a venture firm that invests in biotechnology companies developing multiple therapeutic medicines from a common platform.
- Lorence Kim: Co-founder and Managing PartnerPast Role: Moderna, Chief Financial Officer
About the Company
Ascenta Capital describes itself as a venture firm that invests in biotechnology companies developing multiple therapeutic medicines from a common platform. The firm focuses on early-stage biotech companies — typically those advancing through Phase 1 and Phase 2 clinical trials — and works with them to support their clinical, regulatory,
manufacturing, and capital strategy needs. Ascenta Capital provides concentrated investment and strategic guidance, partnering closely with management teams to help translate scientific research into therapies for patients. The firm pursues a portfolio-construction approach that balances risk by backing multi-asset biotech platforms rather than single-asset startups.
